Potential Macrolide Interaction with Verapamil

Abstract

View all access options for this article.

Periti

Mazzei

Mini

Novelli

. Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet 1992;23:106–31.

Slaughter

Edwards

. Recent advances: The cytochrome P450 enzymes. Ann Pharmacother 1995;29:619–24.

Kroemer

Gautier

Beaune

Henderson

Wolf

Eichelbaum

. Identification of P450 enzymes involved in metabolism of verapamil in humans. Arch Pharmacol 1993;348:332–7.

Schwartz

Keefe

Kirsten

. Prolongation of verapamil elimination kinetics during chronic and oral administration. Am Heart J 1982;104:198–203.

Sasaki

Tateishi

Ebihara

. The effects of age and gender on the stereoselective pharmacokinetics of verapamil. Pharmacol Ther 1993;54: 278–85.

Olkkola

Aranko

Luurila

Hiller

Saarnivaara

Himberg

A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther 1993;53:298–305.

Singh

Ellrodt

Peter

. Verapamil: A review of its pharmacological properties and therapeutic use. Drugs 1978;15:169–97.

Routledge

Shand

. Clinical pharmacokinetics of propranolol. Clin Pharmacokinet 1979;4:73–90.

Hunt

Bottorff

Herring

. Effects of calcium channel blockers on the pharmacokinetics of propranolol stereoisomers. Clin Pharmacol Ther 1990;47:584–91.